FIRMQUARRYResearch workspace

FIRMQUARRY / COMPANY INTELLIGENCE

AUXILIUM BIOTECHNOLOGIES INC.

Other · SAN DIEGO, CA · observed recipient location

View contract history ↗Track with Pro
Data last updated Oct 22, 2026 · Source: official procurement and company-intelligence sources

COMPANY-SPECIFIC CONTRACT CYCLE / THREE-YEAR BASELINE

Is this company winning more—or less—than usual?

Current 12-month net U.S. obligations compared with the company's own annual average over the preceding three years, not a universal benchmark.

Above normal contract activity
Last 12 months · net obligated$1.8MPositive and negative transactions included
Previous 36 months · annual average$695KCompany's own historical run rate
Change from normal+160.9%+$1.1M versus annual baseline
New contracts · last 12 months0Prior 3-year annual avg: 0.0
Expansion research cue—not a growth prediction.

A sustained increase may warrant investigation of hiring, facilities, financing and capacity commitments. Contract obligations do not equal company revenue or necessarily imply expansion.

General information

Legal name
AUXILIUM BIOTECHNOLOGIES INC.
Industry
Other
Observed geography
SAN DIEGO, CA · Observed recipient location
First / latest observed
Oct 23, 2026 — Nov 3, 2026

SUPPORTED COMPANY SIGNALS

Company change signals

Only supported categories appear in the default dossier. Opening from a specific screener keeps that category in focus. Evidence scores are not probabilities.

Expansion+161% vs normal contractsProcurement research cue · not a validated expansion, contraction or move forecast

One source-backed chronology

Timeline

Business change, facilities, workforce, corporate events, and government activity appear chronologically.

  1. Government
    Award increased

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govIncreased by $1.3M27.8% of award valueModification P00010source backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  2. Government
    Award increased

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govIncreased by $515K11% of award valueModification P00009source backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  3. Government
    Award increased

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govIncreased by $345K7.4% of award valueModification P00007source backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  4. Government
    Award adjusted

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govModification P00006Minor contract modificationsource backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  5. Government
    Award adjusted

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govModification P00008Minor contract modificationsource backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  6. Government
    Award increased

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govIncreased by $680K14.6% of award valueModification P00005source backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  7. Government
    Award adjusted

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govModification P00004source backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  8. Government
    Award adjusted

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govModification P00003source backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  9. Government
    Award increased

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govIncreased by $395K8.5% of award valueModification P00002source backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  10. Government
    Award increased

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govIncreased by $380K8.1% of award valueModification P00001source backed · match auto verifiedcollected Oct 23, 2026Official source ↗
  11. Government
    Award increased

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govIncreased by $775K16.6% of award valueModification 0source backed · match auto verifiedcollected Nov 2, 2026Official source ↗
  12. Government
    Award announced

    BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICES

    US_FEDERAL · USAspending.govModification 0source backed · match auto verifiedcollected Oct 23, 2026Official source ↗

Disclosed procurement context

Government Business

Money leads this view. Values represent disclosed obligations and procurement amounts—not company revenue.

Total Net Obligations$4.7MU.S. transaction obligations
12M Net Obligations+$1.8MPrevious 365 days
Latest Award$4.7MSep 6, 2022
Latest Material Adjustment$1.3MJan 26, 2026

Global government business

Markets and currencies remain separate; incompatible currencies are never summed.

MarketDisclosed valueCurrencyLatest activityProcesses
US$0USDSep 6, 20221

Top agencies by net obligations

  1. 01National Aeronautics and Space Administration1 awards$4.7M

Top work locations by net obligations

  1. 01SAN DIEGO, SAN DIEGO, CA1 awards$4.7M

Latest U.S. awards

Explore the most recent records here, or open the full company archive to filter across all available years.

Full contract history ↗
DateContractCompanyBuyer / agencyValueIndustryCountry / work locationOutlook
Sep 6, 2022BIOMANUFACTURING IN SPACE OF DRUG-DELIVERY MEDICAL DEVICESAUXILIUM BIOTECHNOLOGIES INC.National Aeronautics and Space Administration$4.7MOtherSAN DIEGO · CAInsufficient history

GOVERNMENT BUSINESS / ANNUAL HISTORY

Annual net U.S. obligations

Disclosed federal transaction obligations, including deobligations. Not company revenue or contract ceiling.

+0−2022: $775K net obligations$775K20222023: $775K net obligations$775K20232024: $0 net obligations$020242025: $1.3M net obligations$1.3M20252026: $1.8M net obligations$1.8M2026

Historical awards and modifications are preserved as individual records.

Browse all company contracts ↗